Powley, Ian R.
Patel, Meeta
Miles, Gareth
Pringle, Howard
Howells, Lynne
Thomas, Anne
Kettleborough, Catherine
Bryans, Justin
Hammonds, Tim
MacFarlane, Marion
Pritchard, Catrin
Funding for this research was provided by:
Breast Cancer Now (2017NOVPCC1066)
Cancer Research UK (C10604/A25151)
Article History
Received: 8 May 2019
Revised: 30 October 2019
Accepted: 15 November 2019
First Online: 2 January 2020
Ethics approval and consent to participate
: All work with patient samples was performed with full ethical approval provided by the University of Leicester Research Ethics Committee.
: Not applicable.
: Not applicable.
: The authors declare no competing interests.
: This research was supported and funded by the Explant Consortium comprising four partners: The University of Leicester, The MRC Toxicology Unit, Cancer Research UK Therapeutic Discovery Laboratories and LifeArc. Additional support was provided by the CRUK-NIHR Leicester Experimental Cancer Medicine Centre (C10604/A25151). Funding for Gareth Miles was provided by Breast Cancer Now’s Catalyst Programme (2017NOVPCC1066), which is supported by funding from Pfizer.